Work

Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm

Year: 2025

Type: article

Abstract: Ewing sarcoma is a malignant small round blue cell tumor caused by chromosomal translocations that generate aberrant fusion oncogenes, most frequently EWSR1::FLI1. The cell of origin and mechanisms of EWSR1::FLI1-driven transformation have remained unresolved, largely due to the lack of a representative animal model. Using a zebrafish genetic Ewing sarcoma model, we provide evidence for a neural crest origin of this cancer. Neural crest-derived cells uniquely tolerate expression of EWSR1::FLI1, and targeted expression of EWSR1::FLI1 in these cells generates lethal Ewing sarcomas. Single-cell analysis of tumor initiation shows that EWSR1::FLI1 reprograms neural crest-derived cells to a mesoderm-like state, strikingly resulting in ectopic fins throughout the body. By profiling chromatin accessibility and genome-wide EWSR1::FLI1 binding, we find that the fusion oncogene hijacks developmental enhancers for neural crest to mesoderm reprogramming during cancer initiation. These findings show how a single mutation profoundly alters embryonic cell fate decisions to initiate a devastating childhood cancer.

Source: Cell Reports

DOI: 10.1016/j.celrep.2025.116376

Authors: Elena Vasileva, Claire Arata, Yongfeng Luo, Ruben Burgos, J. Gage Crump, James F. Amatruda

Institutions: Children's Hospital Los Angeles, University of Southern California

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,620